vs
CARVANA CO.（CVNA）与费森尤斯医疗（FMS）财务数据对比。点击上方公司名可切换其他公司
CARVANA CO.的季度营收约是费森尤斯医疗的1.0倍（$5.6B vs $5.5B），CARVANA CO.净利率更高（15.3% vs 7.9%，领先7.4%），CARVANA CO.同比增速更快（58.0% vs -0.3%）
Carvana Co.是总部位于美国亚利桑那州坦佩市的线上二手车零售企业，主打线上一站式购车服务，2021年成功入选《财富》500强榜单，是该榜单有史以来最年轻的上榜企业之一。
费森尤斯医疗是德国知名医疗保健企业，核心业务为肾脏透析服务，在全球运营4171家门诊透析中心，服务约34.54万名患者。公司主要为终末期肾病患者提供治疗服务，该类患者需终身每周接受3次透析治疗以维持生命。
CVNA vs FMS — 直观对比
营收规模更大
CVNA
是对方的1.0倍
$5.5B
营收增速更快
CVNA
高出58.3%
-0.3%
净利率更高
CVNA
高出7.4%
7.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $5.6B | $5.5B |
| 净利润 | $857.0M | $434.2M |
| 毛利率 | 18.8% | 27.4% |
| 营业利润率 | 7.6% | 11.7% |
| 净利率 | 15.3% | 7.9% |
| 营收同比 | 58.0% | -0.3% |
| 净利润同比 | 984.8% | 240.4% |
| 每股收益（稀释后） | — | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CVNAFMS
| Q4 25 | $5.6B | $5.5B | ||
| Q3 25 | $5.6B | — | ||
| Q2 25 | $4.8B | — | ||
| Q1 25 | $4.2B | — | ||
| Q4 24 | $3.5B | $5.5B | ||
| Q3 24 | $3.7B | — | ||
| Q2 24 | $3.4B | — | ||
| Q1 24 | $3.1B | — |
净利润CVNAFMS
| Q4 25 | $857.0M | $434.2M | ||
| Q3 25 | $151.0M | — | ||
| Q2 25 | $183.0M | — | ||
| Q1 25 | $216.0M | — | ||
| Q4 24 | $79.0M | $127.6M | ||
| Q3 24 | $85.0M | — | ||
| Q2 24 | $18.0M | — | ||
| Q1 24 | $28.0M | — |
毛利率CVNAFMS
| Q4 25 | 18.8% | 27.4% | ||
| Q3 25 | 20.3% | — | ||
| Q2 25 | 22.0% | — | ||
| Q1 25 | 22.0% | — | ||
| Q4 24 | 21.5% | 25.0% | ||
| Q3 24 | 22.1% | — | ||
| Q2 24 | 21.0% | — | ||
| Q1 24 | 19.3% | — |
营业利润率CVNAFMS
| Q4 25 | 7.6% | 11.7% | ||
| Q3 25 | 9.8% | — | ||
| Q2 25 | 10.6% | — | ||
| Q1 25 | 9.3% | — | ||
| Q4 24 | 7.3% | 5.1% | ||
| Q3 24 | 9.2% | — | ||
| Q2 24 | 7.6% | — | ||
| Q1 24 | 4.4% | — |
净利率CVNAFMS
| Q4 25 | 15.3% | 7.9% | ||
| Q3 25 | 2.7% | — | ||
| Q2 25 | 3.8% | — | ||
| Q1 25 | 5.1% | — | ||
| Q4 24 | 2.2% | 2.3% | ||
| Q3 24 | 2.3% | — | ||
| Q2 24 | 0.5% | — | ||
| Q1 24 | 0.9% | — |
每股收益（稀释后）CVNAFMS
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $0.24 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $2.3B | $1.7B |
| 总债务越低越好 | $4.9B | — |
| 股东权益账面价值 | $3.4B | $15.4B |
| 总资产 | $13.2B | $33.5B |
| 负债/权益比越低杠杆越低 | 1.43× | — |
8季度趋势，按日历期对齐
现金及短期投资CVNAFMS
| Q4 25 | $2.3B | $1.7B | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $1.9B | — | ||
| Q1 25 | $1.9B | — | ||
| Q4 24 | $1.7B | $1.3B | ||
| Q3 24 | $871.0M | — | ||
| Q2 24 | $542.0M | — | ||
| Q1 24 | $252.0M | — |
总债务CVNAFMS
| Q4 25 | $4.9B | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | $5.3B | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
股东权益CVNAFMS
| Q4 25 | $3.4B | $15.4B | ||
| Q3 25 | $2.3B | — | ||
| Q2 25 | $1.7B | — | ||
| Q1 25 | $1.5B | — | ||
| Q4 24 | $1.3B | $17.0B | ||
| Q3 24 | $611.0M | — | ||
| Q2 24 | $526.0M | — | ||
| Q1 24 | $289.0M | — |
总资产CVNAFMS
| Q4 25 | $13.2B | $33.5B | ||
| Q3 25 | $9.9B | — | ||
| Q2 25 | $9.4B | — | ||
| Q1 25 | $8.9B | — | ||
| Q4 24 | $8.5B | $36.3B | ||
| Q3 24 | $7.4B | — | ||
| Q2 24 | $7.2B | — | ||
| Q1 24 | $7.0B | — |
负债/权益比CVNAFMS
| Q4 25 | 1.43× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 4.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $430.0M | $2.9B |
| 自由现金流经营现金流 - 资本支出 | $379.0M | — |
| 自由现金流率自由现金流/营收 | 6.8% | — |
| 资本支出强度资本支出/营收 | 0.9% | — |
| 现金转化率经营现金流/净利润 | 0.50× | 6.67× |
| 过去12个月自由现金流最近4个季度 | $889.0M | — |
8季度趋势，按日历期对齐
经营现金流CVNAFMS
| Q4 25 | $430.0M | $2.9B | ||
| Q3 25 | $345.0M | — | ||
| Q2 25 | $29.0M | — | ||
| Q1 25 | $232.0M | — | ||
| Q4 24 | $60.0M | $2.6B | ||
| Q3 24 | $403.0M | — | ||
| Q2 24 | $354.0M | — | ||
| Q1 24 | $101.0M | — |
自由现金流CVNAFMS
| Q4 25 | $379.0M | — | ||
| Q3 25 | $307.0M | — | ||
| Q2 25 | $-2.0M | — | ||
| Q1 25 | $205.0M | — | ||
| Q4 24 | $36.0M | — | ||
| Q3 24 | $376.0M | — | ||
| Q2 24 | $332.0M | — | ||
| Q1 24 | $83.0M | — |
自由现金流率CVNAFMS
| Q4 25 | 6.8% | — | ||
| Q3 25 | 5.4% | — | ||
| Q2 25 | -0.0% | — | ||
| Q1 25 | 4.8% | — | ||
| Q4 24 | 1.0% | — | ||
| Q3 24 | 10.3% | — | ||
| Q2 24 | 9.7% | — | ||
| Q1 24 | 2.7% | — |
资本支出强度CVNAFMS
| Q4 25 | 0.9% | — | ||
| Q3 25 | 0.7% | — | ||
| Q2 25 | 0.6% | — | ||
| Q1 25 | 0.6% | — | ||
| Q4 24 | 0.7% | — | ||
| Q3 24 | 0.7% | — | ||
| Q2 24 | 0.6% | — | ||
| Q1 24 | 0.6% | — |
现金转化率CVNAFMS
| Q4 25 | 0.50× | 6.67× | ||
| Q3 25 | 2.28× | — | ||
| Q2 25 | 0.16× | — | ||
| Q1 25 | 1.07× | — | ||
| Q4 24 | 0.76× | 20.20× | ||
| Q3 24 | 4.74× | — | ||
| Q2 24 | 19.67× | — | ||
| Q1 24 | 3.61× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CVNA
| Used Vehicle Sales | $4.2B | 74% |
| Wholesale Sales And Revenues | $988.0M | 18% |
| Other | $459.0M | 8% |
FMS
暂无分部数据
